Clinical analysis of colorectal cancer combined with active tuberculosis
10.3760/cma.j.issn.1006-9801.2018.02.010
- VernacularTitle:结直肠癌合并活动性肺结核临床诊疗分析
- Author:
Zonglin LI
1
;
Shuaiqi WANG
;
Hui YAO
;
Xiaoli TIAN
;
Liang XU
Author Information
1. 西南医科大学附属医院胃肠外科
- Keywords:
Colorectal neoplasms;
Active tuberculosis;
Drug therapy;
combination
- From:
Cancer Research and Clinic
2018;30(2):114-115,127
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the treatment methods for colorectal cancer patients combined with active tuberculosis. Methods The clinical data of 8 cases of colorectal cancer combined with active tuberculosis from September 2011 to January 2017 in the Affiliated Hospital of Southwest Medical University were analyzed retrospectively. Results All the patients received tumor radical resection after given intensive anti-tuberculotherapy for 2 to 3 weeks. From the second day after surgery, isonicotinyl hydrazide was done through intravenous infusion. When gastrointestinal function was restored, the preoperative anti-tuberculosis treatment was reused. After 2 mouths, consolidation therapy was done. There were 3 cases of complicating pneumonia and 1 case of complicating anastomotic fistula after surgery.Six courses of FOLFOX4 chemotherapy combined with anti-tuberculosis consolidation treatment were carried out for all the patients. No tuberculosis dissemination or death case occurred. Conclusions After given anti-tuberculotherapy for 2 to 3 weeks, the colorectal cancer patients combined with active tuberculosis could receive tumor radical resection. It is safe and feasible to carry out assisted chemotherapy for tumor during the consolidation anti-tuberculotherapy.
